Morpholine

Morpholine

SCHEMBL7988796

C1COCCN1.CCOc1cccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 5/20 0.42
ALDH1A1 P00352 4/20 0.42
GAA P10253 1/20 0.42
XBP1 P17861 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TP53 P04637 2/20 0.39
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
ICMT O60725 1/20 0.37
GUSB P08236 1/20 0.37
BRD4 O60885 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974404 0.91 SMN1; SMN2 (0.49) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
Morpholine SCHEMBL7991505 0.91 KMT2A (0.55) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
Morpholine SCHEMBL7984416 0.87 KMT2A (0.52) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7985391 0.83 HPGD (0.47) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7974583 0.83 GAA (0.59) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7984451 0.82 ALDH1A1 (0.46) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7974476 0.81 GUSB (0.56) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7985844 0.78 GAA (0.52) HPGDALDH1A1GAATP53KDM4E
SCHEMBL7988590 0.78 ALDH1A1 (0.53) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7975265 0.78 SMN1; SMN2 (0.61) KMT2AHPGDSMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed